Clinical Trial Update: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study of HLA-haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide and b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Velcade (bortezomib)

Snippet

Sponsor: Henry Ford Health System | Conditions: Hematological Malignancy | Phase 2 | Status: RECRUITING